Meeting
2015 Genitourinary Cancers Symposium
Evaluation of the economic impact of the CCP assay in localized prostate cancer.
Authors
E. David Crawford
University of Colorado Health Science Center, Aurora, CO
E. David Crawford , Doria Cole , Nicolas Lewine , Gary Gustavsen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 85)
DOI
10.1200/jco.2015.33.7_suppl.85
Abstract #
85
Poster Bd #
E1
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Clinical characteristics and treatment patterns of patients with high-risk localized prostate cancer (HR LPC) treated with radical prostatectomy (RP) and perioperative hormonal therapy (HT) in Japan, South Korea, and Taiwan.
First Author: Shingo Hatakeyama
Poster
2021 ASCO Quality Care Symposium
Evaluation of drug cost avoidance resulting from conduct of cancer clinical trials in a community-based oncology practice.
First Author: Amit Sanyal
Poster
2020 ASCO Virtual Scientific Program
Total cost of lung cancer care associated with broad panel versus narrow panel sequencing.
First Author: Rogelio Alberto Brito
Poster
2019 ASCO Annual Meeting
Clinical outcomes and genomic analysis in patients with very high-risk clinically localized prostate cancer treated by radical prostatectomy.
First Author: Pedro Isaacsson Velho